Eton Pharmaceuticals (ETON) Research & Development (2018 - 2025)
Eton Pharmaceuticals (ETON) reported Research & Development of $1.8 million for Q4 2025, up 304.36% on a YoY basis from $440198.8 in Q4 2024, and up 60.07% sequentially from $1.1 million in Q3 2025.
Eton Pharmaceuticals (ETON) Research & Development (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 8 years of Research & Development data on file, last reported at $1.8 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 304.36% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $7.8 million (up 138.56% YoY), and the FY2025 full-year result was $7.8 million, up 138.56% from the prior year.
- Research & Development rose to $1.8 million in Q4 2025, from $1.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $3.7 million in Q2 2025 to a low of -$871000.0 in Q4 2024.
- A 5-year average of $1.2 million and a median of $995500.0 in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development sank 183.19% in 2024 and jumped 304.36% in 2025, its largest moves.
- Tracing ETON's Research & Development over 5 years: stood at $681000.0 in 2021, then jumped by 38.62% to $944000.0 in 2022, then grew by 10.91% to $1.0 million in 2023, then slumped by 183.19% to -$871000.0 in 2024, then jumped by 304.36% to $1.8 million in 2025.
- Business Quant data shows ETON's Research & Development at $1.8 million in Q4 2025, $1.1 million in Q3 2025, and $3.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 138.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.12 Bn | 13.10 Mn | 1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | -871,000.00 |
| Sep 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 651,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 615,000.00 |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 535,000.00 |
| Dec 31, 2022 | 944,000.00 |
| Sep 30, 2022 | 744,000.00 |
| Jun 30, 2022 | 690,000.00 |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 681,000.00 |
| Sep 30, 2021 | 2.68 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | 886,000.00 |